PRF Technologies (PRFX) Preferred Shares (2019 - 2023)

PRF Technologies (PRFX) posted quarterly Preferred Shares of $1.1 million for Q4 2023, down 92.56% on a QoQ basis from $15.2 million in Q4 2019.

PRF Technologies (PRFX) Preferred Shares (2019 - 2023) Analysis & Trends

PRF Technologies (PRFX) has reported Preferred Shares for 2 consecutive years, with $1.1 million the latest figure, recorded in Q4 2023.

  • Quarterly Preferred Shares changed N/A year-over-year to $1.1 million in Q4 2023, while the trailing twelve-month figure through Dec 2023 was $1.1 million (changed N/A YoY) and the FY2023 annual result came in at $1.1 million, changed N/A from the prior year.
  • Preferred Shares retreated to $1.1 million in Q4 2023 per PRFX's latest filing, from $15.2 million in the prior quarter.
  • Over the last five years, Preferred Shares for PRFX reached as high as $15.2 million in Q4 2019 and fell as low as $1.1 million in Q4 2023.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Shares (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 PRF Technologies 745,168.93 451,168.93 - -

Historic Data

Download Data
DateValue
Dec 31, 2023 1.14 Mn
Dec 31, 2019 15.25 Mn